Main Article Content
Because of the widespread arousing interest in Helicobacter pylori infection,pharmacological treatment for peptic ulcer faces great changes. Although severalcontroversial aspects about this infection are still suspended in medical profession. There area lot of evidences which have proven the benefits of eradication H pylori from the gut of peptic patients. Moreover, NIH consensus conference has approved eradication H pylori inevery peptic patient who is infected with this spiral organism. This article is hoped to beuseful for catching up pharmacological management on this catchy name, H pyloriin pepticdisease. It reviews about importance, basic clinical studies, and gastric pharmacology. Various regimens of treatment are summarized. Some of general considerations in drugtherapy are also discussed.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.